scorecardresearch
Moderna

Moderna

 

More Stories on Moderna
Earlier this month, Britain's Joint Committee on Vaccination and Immunization said vaccines should be given to 12- to 15-year-olds with underlying health conditions

UK okays vaccines for 12-15 year olds, looks to avert lockdowns

Sep 14, 2021

Vaccinations for children and booster shots for at-risk adults are expected to be part of a "tool kit" to control COVID-19 infections this fall and winter that Prime Minister Boris Johnson plans to announce Tuesday at a news conference

Covaxin in one of the vaccines being administered in the country under the nationwide vaccination programme against coronavirus.

WHO to approve Bharat Biotech's COVID-19 vaccine Covaxin this week: Report

Sep 13, 2021

So far, the WHO has approved COVID-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio or Serum Institute of India, Johnson & Johnson, Moderna, and Sinopharm.

Gottlieb said on the CBS show Face the Nation that in a best-case scenario, the Pfizer vaccine could be ready by October 31 for younger children

COVID-19 vaccine for 5-11 years age group likely to be out in US by October-end: Report

Sep 13, 2021

A report in The New York Times quoted two health experts as saying that COVID vaccines for children aged 5 to 11 could be available as soon as the end of October

Moderna's COVID-19 vaccine is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson & Johnson, suggests a new study

Moderna's COVID-19 vaccine more effective against Delta variant than Pfizer, J&J, reveals study

Sep 11, 2021

Published in Morbidity and Mortality Weekly Report, the study indicates that Moderna was 95% effective at preventing hospitalisation among adults aged 18 years and older, while Pfizer was 80% effective and J&J was 60% effective

The FDA granted full approval last month for the use of Pfizer Inc's vaccine in people over the age of 16 based on a six-month follow-up from the trial. Photo: Reuters

US heath regulator may authorise COVID-19 vaccine for kids based on two months of safety data

Sep 10, 2021

The US Food and Drug Administration says it is looking to complete the data review as quickly as possible, likely in a matter of weeks rather than months

Moderna provided updates on its ongoing mid-stage trial testing its authorized COVID-19 vaccine in children aged 6 months to less than 12 years

Moderna working on single-dose booster shot for COVID-19, flu

Sep 09, 2021

"Our number one priority as a company right now is to bring to market a Pan-respiratory annual booster vaccine, which we plan to always customize and upgrade," Chief Executive Officer Stéphane Bancel said during Moderna's R&D day

The companies on Aug. 26 announced suspension of 1.63 million doses produced at the line after reports of contamination

COVID-19 vaccine: Moderna, Japan partner recall 1.6 million doses

Sep 02, 2021

The two companies said an investigation at a Spanish factory that produced the vials in question concluded the contamination occurred in the process of putting stops on the vials

There have been 565,400 doses within the tons with complaints, and “as a precaution” Moderna postpone the lot and two adjoining ones

Moderna suspends shipments of vaccine to Japan after reports of contamination

Aug 26, 2021

The contamination might have been attributable to a manufacturing downside at one of many manufacturing strains at its contract manufacturing web site in Spain, the corporate mentioned

“It’s the best way to protect ourselves from new variants that may arise,” US President Joe Biden told reporters at the White House

US to offer COVID-19 vaccine booster shots from Sept

Aug 19, 2021

US officials will offer a third shot to Americans who received their initial inoculation of two-dose COVID-19 vaccines made by Moderna Inc and by Pfizer Inc and BioNTech AG at least eight months earlier, the Department of Health and Human Services said

Top US health officials say they based their decision to offer boosters on data showing that the protectiveness of COVID-19 shots currently authorised in the US begins to diminish in the months after the shots are given

Delta variant threat: US to offer COVID-19 vaccine booster shots from Sept

Aug 18, 2021

The booster shots initially will be given primarily to healthcare workers, nursing home residents and older people, all of whom were among the first groups to be vaccinated in late 2020 and early 2021

Both the Moderna and Pfizer-BioNTech vaccines are based on messenger RNA (mRNA) technology

Moderna claims its COVID-19 vaccine remains 93% effective 4-6 months after second dose

Aug 05, 2021

Moderna's vaccine was authorized for emergency use in adults in the United States in December and has since been cleared for emergency or conditional use in adults in more than 50 countries